[Late neonatal hypocalcemia. Apropos of 33 cases treated with 1 alpha-hydroxycholecalciferol].
Thirty-three observations of late-onset neonatal hypocalcemia were reviewed retrospectively. Their etiological, clinical and biological features were consistent with a transient congenital hypoparathyroidism, associated with a materno-foetal vitamin D deficiency. 1 alpha-hydroxycholecalciferol was used for rapid correction of calcemia and proved to be satisfactorily metabolized after its oral administration.
Wright
C
C
Service de pédiatrie, hôpital Edouard-Herriot, Lyon, France.
David
L
L
Chapuy
M C
MC
Delvin
E
E
Putet
G
G
Salle
B L
BL
D002118:Calcium / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use*; D006996:Hypocalcemia / Q000151:congenital* / Q000188:drug therapy / Q000209:etiology; D007011:Hypoparathyroidism / Q000209:etiology / Q000503:physiopathology; D007223:Infant; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy / Q000209:etiology; D010758:Phosphorus / Q000097:blood; D011247:Pregnancy; D012189:Retrospective Studies; D013997:Time Factors; D014808:Vitamin D Deficiency / Q000503:physiopathology
D006887:Hydroxycholecalciferols; D010758:Phosphorus; D002118:Calcium; C008088:alfacalcidol
Etude de l'hypocalcémie néo-natale tardive. A propos de 33 observations traitées par le 1 alpha-hydroxycholécalciférol.